Literature DB >> 22455733

C60 fullerene derivatized nanoparticles and their application to therapeutics.

Chun-Mao Lin1, Tan-Yi Lu.   

Abstract

Fullerenes can be formed into many new materials and devices. They have a wide range of applications in medicine, electronics, biomaterials, and energy production. An overview of the nanostructure and the physical and chemical characteristics of fullerene-drug derivatives is given. The biological behavior of fullerene derivatives shows their potential to medical application fields because C(60) is rapidly absorbed by tissues and is excreted through urinary tract and enterons, which reveals low toxicity in vitro and in vivo studies. Nanomedicine has become one of the most promising areas of nanotechnology, while many have claimed its therapeutic use against cancer, human immunodeficiency virus (HIV), and neurodegenerative disorders. Water-soluble C(60) fullerene derivatives that come from chemical modification largely enhance the biological efficacy. The blood-brain barrier (BBB) is a physical barrier composed of endothelial tight junctions that restrict the paracellular permeability. A major challenge facing neuropharmacology is to find compounds that can be delivered into the brain through the bloodstream. Fullerene C(60) was demonstratively able to cross the BBB by hybridizing a biologically active moiety dyad, which provides a promising clue as a pharmacological therapy of neural disorders.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22455733     DOI: 10.2174/187221012800270135

Source DB:  PubMed          Journal:  Recent Pat Nanotechnol        ISSN: 1872-2105            Impact factor:   1.952


  8 in total

1.  Contrasting effects of nanoparticle-protein attraction on amyloid aggregation.

Authors:  Slaven Radic; Thomas P Davis; Pu Chun Ke; Feng Ding
Journal:  RSC Adv       Date:  2015-12-01       Impact factor: 3.361

2.  NanoEHS beyond Toxicity - Focusing on Biocorona.

Authors:  Sijie Lin; Monika Mortimer; Ran Chen; Aleksandr Kakinen; Jim E Riviere; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Environ Sci Nano       Date:  2017-06-01

3.  Synergistic mitotoxicity of chloromethanes and fullerene C60 nanoaggregates in Daphnia magna midgut epithelial cells.

Authors:  Mariana Seke; Milica Markelic; Arian Morina; Danica Jovic; Aleksandra Korac; Dragana Milicic; Aleksandar Djordjevic
Journal:  Protoplasma       Date:  2016-12-03       Impact factor: 3.356

4.  Nanotherapeutics Engineered to Cross the Blood-Brain Barrier for Advanced Drug Delivery to the Central Nervous System.

Authors:  Jinhwan Kim; Song Ih Ahn; YongTae Kim
Journal:  J Ind Eng Chem       Date:  2019-01-28       Impact factor: 6.064

5.  A zeta potential value determines the aggregate's size of penta-substituted [60]fullerene derivatives in aqueous suspension whereas positive charge is required for toxicity against bacterial cells.

Authors:  Dmitry G Deryabin; Ludmila V Efremova; Alexey S Vasilchenko; Evgeniya V Saidakova; Elena A Sizova; Pavel A Troshin; Alexander V Zhilenkov; Ekaterina A Khakina; Ekaterina E Khakina
Journal:  J Nanobiotechnology       Date:  2015-08-08       Impact factor: 10.435

Review 6.  Photodynamic immunotherapy of cancers based on nanotechnology: recent advances and future challenges.

Authors:  Zhaoyuan Liu; Zhongjian Xie; Wenting Li; Xinqiang Wu; Xiaofeng Jiang; Guanhua Li; Liangqi Cao; Dawei Zhang; Qiwen Wang; Ping Xue; Han Zhang
Journal:  J Nanobiotechnology       Date:  2021-05-29       Impact factor: 10.435

Review 7.  Dodging blood brain barrier with "nano" warriors: Novel strategy against ischemic stroke.

Authors:  Suhel Parvez; Medha Kaushik; Mubashshir Ali; Mohammad Mumtaz Alam; Javed Ali; Heena Tabassum; Pooja Kaushik
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.600

Review 8.  A Review on Nanocarrier Mediated Treatment and Management of Triple Negative Breast Cancer: A Saudi Arabian Scenario.

Authors:  Insha Nahvi; Sana Belkahla; Supratim Biswas; Suparna Chakraborty
Journal:  Front Oncol       Date:  2022-07-22       Impact factor: 5.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.